X
Sanofi buys UK’s Kymab and inflammatory disease hopeful for $1.45bn
https://pharmaphorum.com/news/sanofi-buys-uks-kymab-and-inflammatory-disease-hopeful-for-1-45bn/
Kymab
Kymab signs immuno-oncology deal for bi-specific antibodies
UK and Chinese antibody companies collaborate in immuno-oncology
UK’s Kymab could help develop HIV vaccine
Biotech’s Kymouse could hold the key to vaccines.
Will the UK ever produce a world-class biotech company?
Kymab, F-star and Mission Therapeutics among crop of new UK biotechs.